← Eichor
Study identifier: NCT04275557 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Using Radiogenomics to Predict Malignant Potential of Intraductal Papillary Mucinous Neoplasms of the Pancreas

Condition: Pancreatic Cancer · Pancreatic Cyst  ·  Sponsor: H. Lee Moffitt Cancer Center and Research Institute

PhaseN/A
Planned participants1174
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

The Florida Pancreas Collaborative wants to partner with individuals who are known to have, or are suspected to have a pancreatic lesion, tumor, cyst, mass, cancer, or pancreatitis and are undergoing diagnosis and treatment at a participating institution. The goals of this project are to build a large database of information obtained from blood, tissue, medical images, surveys and information from routine care to develop noninvasive diagnostic approaches that could be used as decision-making tools to effectively personalize clinical care.

This description comes directly from the study's public registry record.

Talk to the study team

Toni Basinski, MS  ·  813-745-6360  ·  Toni.Basinski@moffitt.org

Always discuss trial participation with your own doctor first.

Locations (3)

Florida Research Institute (FRI)Lakewood Rch, Florida, United StatesRecruiting
Sylvester Comprehensive Cancer Center & Jackson Memorial HospitalMiami, Florida, United StatesRecruiting
Moffitt Cancer CenterTampa, Florida, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04275557